Thursday, January 10, 2008

ACTC

Advanced Cell Technology Announces Creation of Human Embryonic Stem Cell Lines Without the Destruction of Embryos


-Breakthrough Approach Improves Efficiency to Levels Reported in the Conventional Stem Cell Derivation Techniques-

At about 20 cents a share, a worthy speculation.

A

1 comment:

Anonymous said...

Just imagine being at half the yearly HIGH :)